KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Non-Current Deffered Revenue: 2020-2024

Historic Non-Current Deffered Revenue for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Dec 2024 value amounting to $98.8 million.

  • Ginkgo Bioworks Holdings' Non-Current Deffered Revenue fell 29.62% to $74.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $74.1 million, marking a year-over-year decrease of 29.62%. This contributed to the annual value of $98.8 million for FY2024, which is 37.50% down from last year.
  • According to the latest figures from FY2024, Ginkgo Bioworks Holdings' Non-Current Deffered Revenue is $98.8 million, which was down 37.50% from $158.1 million recorded in FY2023.
  • In the past 5 years, Ginkgo Bioworks Holdings' Non-Current Deffered Revenue registered a high of $174.8 million during FY2022, and its lowest value of $98.8 million during FY2024.
  • Moreover, its 3-year median value for Non-Current Deffered Revenue was $158.1 million (2023), whereas its average is $143.9 million.
  • Per our database at Business Quant, Ginkgo Bioworks Holdings' Non-Current Deffered Revenue surged by 56.54% in 2021 and then plummeted by 37.50% in 2024.
  • Ginkgo Bioworks Holdings' Non-Current Deffered Revenue (Yearly) stood at $99.7 million in 2020, then spiked by 56.54% to $156.0 million in 2021, then grew by 12.04% to $174.8 million in 2022, then declined by 9.56% to $158.1 million in 2023, then crashed by 37.50% to $98.8 million in 2024.